Pre-CV Screening Inflates Drug Response AUCs by ≥0.10
Featured receives full write-ups, Notable gets short mentions, and Candidate remains visible for manual review instead of being hidden.
Also Worth Noting
-
Preprint source; Domain relevant (2 hits): biomarker discovery, drug response; AIDD core boost (2 hits): biomarker discovery, drug response; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Core venue: Journal of Chemical Information; Domain relevant (1 hits): drug discovery; AIDD core boost (1 hits): drug discovery; Priority topic: general AIDD
Candidate
-
Peer-reviewed journal source; Top institution: Roche; Domain relevant (2 hits): drug design, structure-based drug design; AIDD core boost (2 hits): drug design, structure-based drug design; Priority topic: molecule design
-
Peer-reviewed journal source; Domain relevant (4 hits): drug design, drug discovery, molecular docking, virtual screening; AIDD core boost (4 hits): drug design, drug discovery, molecular docking, virtual screening; Priority topic: binding and screening
-
Peer-reviewed journal source; Domain relevant (4 hits): drug design, drug discovery, structure-based drug design, medicinal chemistry; AIDD core boost (3 hits): drug design, drug discovery, structure-based drug design; Priority topic: molecule design
-
Peer-reviewed journal source; Domain relevant (4 hits): drug design, binding affinity, molecular docking, ADMET; AIDD core boost (4 hits): drug design, binding affinity, molecular docking, ADMET; Priority topic: ADMET and developability
-
Peer-reviewed journal source; Domain relevant (3 hits): drug discovery, biomarker discovery, drug response; AIDD core boost (3 hits): drug discovery, biomarker discovery, drug response; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Domain relevant (3 hits): drug discovery, biomarker discovery, drug screening; AIDD core boost (2 hits): drug discovery, biomarker discovery; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Domain relevant (2 hits): drug design, drug discovery; AIDD core boost (2 hits): drug design, drug discovery; Priority topic: molecule design
-
Peer-reviewed journal source; Domain relevant (2 hits): biomarker discovery, drug response; AIDD core boost (2 hits): biomarker discovery, drug response; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Domain relevant (2 hits): drug discovery, biomarker discovery; AIDD core boost (2 hits): drug discovery, biomarker discovery; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Domain relevant (2 hits): drug discovery, drug response; AIDD core boost (2 hits): drug discovery, drug response; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Elite venue: Cell Systems; Domain relevant (2 hits): therapeutic target, small molecule; Priority topic: ADMET and developability
-
Peer-reviewed journal source; Domain relevant (2 hits): binding affinity, small molecule; AIDD core boost (1 hits): binding affinity; Priority topic: binding and screening
-
Peer-reviewed journal source; Top institution: Nanjing University; Core venue: Journal of Computer-Aided Molecular Design; Priority topic: binding and screening
-
Peer-reviewed journal source; Domain relevant (2 hits): biomarker discovery, drug screening; AIDD core boost (1 hits): biomarker discovery; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Domain relevant (1 hits): molecular docking; AIDD core boost (1 hits): molecular docking; Priority topic: binding and screening
-
Peer-reviewed journal source; Domain relevant (1 hits): drug discovery; AIDD core boost (1 hits): drug discovery; Priority topic: biologics design
-
Peer-reviewed journal source; Domain relevant (1 hits): drug discovery; AIDD core boost (1 hits): drug discovery; Priority topic: biologics design
-
Peer-reviewed journal source; Domain relevant (1 hits): drug response; AIDD core boost (1 hits): drug response; Priority topic: omics and biomarkers
-
Peer-reviewed journal source; Core venue: Journal of Computer-Aided Molecular Design; Priority topic: molecule design
-
Peer-reviewed journal source; AIDD core boost (1 hits): drug-target interaction; Priority topic: binding and screening
-
Peer-reviewed journal source; Domain relevant (1 hits): phenotypic profiling; Priority topic: biologics design
-
Preprint source; Domain relevant (1 hits): de novo design; Priority topic: molecule design
-
Peer-reviewed journal source; Priority topic: screening and target discovery
-
Preprint source; Domain relevant (1 hits): SAR; Priority topic: structure modeling
-
Peer-reviewed journal source; Priority topic: biologics design
-
Peer-reviewed journal source; Priority topic: biologics design
-
Peer-reviewed journal source; Priority topic: omics and biomarkers
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Peer-reviewed journal source
-
Preprint source; Priority topic: omics and biomarkers